Home/Filings/4/0000950170-25-068294
4//SEC Filing

Winer Gary M 4

Accession 0000950170-25-068294

CIK 0001828673other

Filed

May 8, 8:00 PM ET

Accepted

May 9, 5:33 PM ET

Size

7.2 KB

Accession

0000950170-25-068294

Insider Transaction Report

Form 4
Period: 2025-05-07
Winer Gary M
Director
Transactions
  • Purchase

    Common Stock

    2025-05-08$26.00/sh+2,308$60,0082,733 total
  • Purchase

    Common Stock Purchase Warrant

    2025-05-07+1,1541,154 total
    Exercise: $26.00From: 2025-05-07Exp: 2030-05-07Common Stock (1,154 underlying)
Footnotes (1)
  • [F1]These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025, along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company.

Documents

1 file

Issuer

HCW Biologics Inc.

CIK 0001828673

Entity typeother

Related Parties

1
  • filerCIK 0001822095

Filing Metadata

Form type
4
Filed
May 8, 8:00 PM ET
Accepted
May 9, 5:33 PM ET
Size
7.2 KB